![](https://www.ncardia.com/hubfs/May%2012_%20social%20post@1x.png)
The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models
![](https://www.ncardia.com/hubfs/September%2030_%20FDA%20modernization%20act.png)
FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials
![](https://www.ncardia.com/hubfs/Jan%205_%20Press%20release%20%281%29.png)
Press release: Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth
![](https://www.ncardia.com/hubfs/Blog%20Featured%20Images/Featured%20image_Press%20release%201%20Cellistic.png)
Press release: Ncardia launches Cellistic, an iPSC cell therapy CDMO
![](https://www.ncardia.com/hubfs/Imported_Blog_Media/7bdc6555e785f60c-450x0-85-files-News-Andy-Holt.jpg)
Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
![](https://www.ncardia.com/hubfs/Blog%20Featured%20Images/Featured%20image_Press%20release%202%20Kiniciti.png)
Press release: Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings